Gene therapies hold immense promise for treating sight loss. These therapies use a modified, harmless virus to deliver ...

DELRAY BEACH, FL / ACCESS Newswire / August 12, 2025 / Adolore BioTherapeutics, Inc., ("Company" or "Adolore") announced that ...

At 22, Daniel Cressy is making history as Louisiana’s first sickle cell gene therapy patient. The treatment could be a cure ...

An interview with Philip Vanek, chief commercialization officer of the International Society for Cell & Gene Therapy (ISCT), ...

An expert discusses how community-based gene therapy administration has broadened treatment options for patients with ...

Haematological cancers are a recognised potential side effect with Skysona and were already mentioned in a boxed warning on ...

The CDMO’s new services at its Hopewell, NJ facility delivers scalable, phase-appropriate production, in-house quality ...

The use of artificial intelligence for batch monitoring and digital twin development are redefining process control — ...

After a strong launch for its cancer gene therapy, Ferring Pharmaceuticals is setting the stage for long-term growth.

Adding a MET gene inhibitor enhances the effect of combined chemotherapy and immunotherapy in small cell lung cancer (SCLC), ...

DELRAY BEACH, FL / ACCESS Newswire / August 12, 2025 / Adolore BioTherapeutics, Inc., ("Company" or "Adolore") announced that Roy Clifford Levitt, MD, Clinical Professor at the University of Miami, Pr ...

Currently, GenAns Biotech is conducting investigator-initiated trials for several gene therapies, including GA001 for ...